Treatment and subsequent prognosis in locally recurrent rectal cancer: a multicenter retrospective study of 498 patients

[1] Gerard JP(2006)Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 4620-4625

[2] Conroy T(2004)Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740

[3] Bonnetain F(2019)Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial Ann Surg 269 589-595

[4] Bouche O(2015)A randomized trial of laparoscopic versus open surgery for rectal cancer N Engl J Med 372 1324-1332

[5] Chapet O(2014)Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial Lancet Oncol 15 767-774

[6] Closon-Dejardin MT(2019)Disease-free survival and local recurrence after laparoscopic-assisted resection or open resection for rectal cancer: the Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial Ann Surg 269 596-602

[7] Untereiner M(2018)Management and prognosis of locally recurrent rectal cancer - a national population-based study Eur J Surg Oncol 44 100-107

[8] Leduc B(2013)Pelvic exenteration for rectal cancer: a systematic review Dis Colon Rectum 56 519-531

[9] Francois E(2019)Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer Br J Surg 106 790-798

[10] Maurel J(2019)Treatment and survival of locally recurrent rectal cancer: a cross-sectional population study 15 years after the Dutch TME trial Eur J Surg Oncol 45 2059-2069

[1] Gerard JP(2006)Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 4620-4625

[2] Conroy T(2004)Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740

[3] Bonnetain F(2019)Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial Ann Surg 269 589-595

[4] Bouche O(2015)A randomized trial of laparoscopic versus open surgery for rectal cancer N Engl J Med 372 1324-1332

[5] Chapet O(2014)Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial Lancet Oncol 15 767-774

[6] Closon-Dejardin MT(2019)Disease-free survival and local recurrence after laparoscopic-assisted resection or open resection for rectal cancer: the Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial Ann Surg 269 596-602

[7] Untereiner M(2018)Management and prognosis of locally recurrent rectal cancer - a national population-based study Eur J Surg Oncol 44 100-107

[8] Leduc B(2013)Pelvic exenteration for rectal cancer: a systematic review Dis Colon Rectum 56 519-531

[9] Francois E(2019)Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer Br J Surg 106 790-798

[10] Maurel J(2019)Treatment and survival of locally recurrent rectal cancer: a cross-sectional population study 15 years after the Dutch TME trial Eur J Surg Oncol 45 2059-2069